Senior insider sale
President and CEO at ACUMEN PHARMACEUTICALS, INC. — senior position signals high conviction
$163.1K
86.01K shares
OCONNELL DANIEL JOSEPH plans to sell 86.01K shares of ACUMEN PHARMACEUTICALS, INC. valued at approximately $163.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/17/2026 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 2.69K | — |
| Total | 2.69K | ||
Completed
Units to sell
9.35K
Market value
$16.9K
Units to sell
5.39K
Market value
$9.3K
Units to sell
12.94K
Market value
$22.8K
Units to sell
8.14K
Market value
$14.8K
Units to sell
37.76K
Market value
$75.0K
Units to sell
5.10K
Market value
$10.0K
Units to sell
4.65K
Market value
$9.2K
Planned — Approximate Date
Units to sell
2.69K
Market value
$5.1K
Units
86.01K
Value
$163.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/21/2026 | 9.35K | $16.9K | — | Completed |
1/12/2026 | 5.39K | $9.3K | — | Completed |
1/9/2026 | 12.94K | $22.8K | — | Completed |
1/8/2026 | 8.14K | $14.8K | — | Completed |
1/7/2026 | 37.76K | $75.0K | — | Completed |
1/6/2026 | 5.10K | $10.0K | — | Completed |
1/5/2026 | 4.65K | $9.2K | — | Completed |
| Planned — Approximate Date | ||||
1/22/2026 | 2.69K | $5.1K | NASDAQ | Planned |
| Total | 86.01K | $163.1K | ||